Материалы доступны только для специалистов сферы здравоохранения. Авторизуйтесь или зарегистрируйтесь.
Оценка эффективности тромбопрофилактики при синдроме гиперстимуляции яичников
Материалы доступны только для специалистов сферы здравоохранения. Авторизуйтесь или зарегистрируйтесь.
Ключевые слова: синдром гиперстимуляции яичников, тромбопрофилактика, низкомолекулярный гепарин.
________________________________________________
Ovarian hyperstimulation syndrome (OHSS) is a relatively common complication of ovarian stimulation. The pathophysiology of OHSS is characterised by increased capillary permeability. As a consequence of this, there is a fluid shift into third-space causing hemoconcentration, it may contribute to hypercoagulable state, with increased risk of venous thromboembolism. The article presents modern data on prevention of thromboembolic complication in OHSS patients with special focus on an approach to determining the antithrombitic therapy effectiveness.
Key words: ovarian hyperstimulation syndrome, thromboprophylaxis, low-molecular-weight-heparin.
2. Bates SM, Greer IA, Pabinger I et al. American College of Chest Physicians. Venous thromboembolism, thrombophilia, antithrombotic therapy, and pregnancy: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest 2008; 133 (Suppl. 6): S844–86.
3. Shmorgun D, Claman P. The diagnosis and management of ovarian hyperstimulation syndrome. J Obstet Gynaecol Can 2011; 11: 1156–62.
4. Chin-Der Chen, Shee-Uan Chen, Yu-Shih Yang. Prevention and management of ovatian hyperstimulation syndrome. Best Pract Research Clin Obstet Gynaecol 2012; 26: 812–27.
5. Rova K, Passmark H, Lindqvist PG. Venous thromboembolism in relation to in vitro fertilization: an approach to determinihg the incidence and increase in risk in succrssful cycles. Fertil Steril 2012; 97 (1): 95–100.
6. Budev M, Arroliga A, Falcone T. Ovarian hyperstimulation syndrome. Crit Care Med 2005; 33: 301–6.
7. Корнеева И.Е. Синдром гиперстимуляции яичников. В кн.: Бесплодный брак. Под ред. В.И.Кулакова. М.: ГЭОТАР-Медиa, 2006; 449–96.
8. Kerkela E, Skottman H, Friden B et al. Exclusion of coding-region mutations in luteinizing hormone and follicle-stimulating hormone receptor genes as the cause of ovarian hyperstimulation syndrome. Fertil Steril 2007; 87 (3): 603–6.
9. Российские клинические рекомендации по диагностике, лечению и профилактике венозных тромбоэмболических осложнений. Флебология. 2010; 4 (2): 6–27.
10. American College of Obstetricians and Gynecologists (ACOG). Inherited thrombophilias in pregnancy. Washington (DC): American College of Obstetricians and Gynecologists (ACOG), 2010.
11. Royal College of Obstetricians and Gynaecologists. Reducing the risk of thrombosis and embolism during pregnancy and the puerperium Green-top. Guideline 2009; 37.
12. Берковский А.Л., Сергеева Е.В., Суворова А.В., Козлова А.А. Методы определения активности гепарина. Методическое руководство. М., 2011.
13. Российские клинические рекомендации по диагностике, лечению и профилактике венозных тромбоэмболических осложнений. Флебология. 2010; 4 (2): 6–27.
________________________________________________
1. Федеральные клинические рекомендации. Диагностика и лечение синдрома гиперстимуляции яичников. М., 2013.
2. Bates SM, Greer IA, Pabinger I et al. American College of Chest Physicians. Venous thromboembolism, thrombophilia, antithrombotic therapy, and pregnancy: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest 2008; 133 (Suppl. 6): S844–86.
3. Shmorgun D, Claman P. The diagnosis and management of ovarian hyperstimulation syndrome. J Obstet Gynaecol Can 2011; 11: 1156–62.
4. Chin-Der Chen, Shee-Uan Chen, Yu-Shih Yang. Prevention and management of ovatian hyperstimulation syndrome. Best Pract Research Clin Obstet Gynaecol 2012; 26: 812–27.
5. Rova K, Passmark H, Lindqvist PG. Venous thromboembolism in relation to in vitro fertilization: an approach to determinihg the incidence and increase in risk in succrssful cycles. Fertil Steril 2012; 97 (1): 95–100.
6. Budev M, Arroliga A, Falcone T. Ovarian hyperstimulation syndrome. Crit Care Med 2005; 33: 301–6.
7. Корнеева И.Е. Синдром гиперстимуляции яичников. В кн.: Бесплодный брак. Под ред. В.И.Кулакова. М.: ГЭОТАР-Медиa, 2006; 449–96.
8. Kerkela E, Skottman H, Friden B et al. Exclusion of coding-region mutations in luteinizing hormone and follicle-stimulating hormone receptor genes as the cause of ovarian hyperstimulation syndrome. Fertil Steril 2007; 87 (3): 603–6.
9. Российские клинические рекомендации по диагностике, лечению и профилактике венозных тромбоэмболических осложнений. Флебология. 2010; 4 (2): 6–27.
10. American College of Obstetricians and Gynecologists (ACOG). Inherited thrombophilias in pregnancy. Washington (DC): American College of Obstetricians and Gynecologists (ACOG), 2010.
11. Royal College of Obstetricians and Gynaecologists. Reducing the risk of thrombosis and embolism during pregnancy and the puerperium Green-top. Guideline 2009; 37.
12. Берковский А.Л., Сергеева Е.В., Суворова А.В., Козлова А.А. Методы определения активности гепарина. Методическое руководство. М., 2011.
13. Российские клинические рекомендации по диагностике, лечению и профилактике венозных тромбоэмболических осложнений. Флебология. 2010; 4 (2): 6–27.
ФГБУ Федеральный медицинский исследовательский центр им. В.А.Алмазова Минздрава России, Санкт-Петербург
________________________________________________
I.E.Zazerskaya, N.A.Osipova, T.V.Vavilova, L.V.Barabanova, K.S.Konradi